Cullinan Therapeutics (CGEM) EPS (Basic) (2020 - 2026)
Cullinan Therapeutics (CGEM) posted quarterly EPS (Basic) of -$0.87 for Q1 2026, down 4.71% year-over-year from -$0.91 in Q1 2025, and down 0.94% quarter-over-quarter from -$0.86 in Q4 2025.
Powered by 
Analysis
Cullinan Therapeutics (CGEM) EPS (Basic) (2020 - 2026) Analysis & Trends
Cullinan Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.87 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 4.71% year-over-year to -$0.87; the TTM figure through Mar 2026 stood at -$3.72 (up 30.01% YoY), while the FY2025 annual figure was -$3.72, down 51.52% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.87, down from -$0.86 in the prior quarter.
- The five-year high for EPS (Basic) was $3.88 in Q2 2022, with the low at -$3.32 in Q4 2024.
- The 5-year median for EPS (Basic) is -$0.86 (2025), against an average of -$0.73.
- Peak annual rise in EPS (Basic) reached 1121.63% in 2022, while the deepest fall reached 958.34% in 2022.
- Cullinan Therapeutics' EPS (Basic) stood at -$0.6 in 2022, then sank by 116.16% to -$1.29 in 2023, then sank by 156.41% to -$3.32 in 2024, then surged by 74.16% to -$0.86 in 2025, then decreased by 0.94% to -$0.87 in 2026.
- Business Quant data shows CGEM's EPS (Basic) at -$0.87 in Q1 2026, -$0.86 in Q4 2025, and -$0.88 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Cullinan Therapeutics | 1.37 Bn | 1.37 Bn | - | -0.87 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.87 |
| Mar 31, 2026 | -0.82 |
| Dec 31, 2025 | -0.86 |
| Sep 30, 2025 | -0.85 |
| Jun 30, 2025 | -1.17 |
| Mar 31, 2025 | -0.82 |
| Dec 31, 2024 | -0.87 |
| Sep 30, 2024 | -0.69 |
| Jun 30, 2024 | -0.75 |
| Mar 31, 2024 | -0.85 |
| Dec 31, 2023 | -0.61 |
| Sep 30, 2023 | -0.92 |
| Jun 30, 2023 | -0.81 |
| Mar 31, 2023 | -1.43 |
| Dec 31, 2022 | -0.60 |
| Sep 30, 2022 | -0.55 |
| Jun 30, 2022 | 3.88 |
| Mar 31, 2022 | -0.29 |
| Dec 31, 2021 | -0.79 |
| Sep 30, 2021 | -0.42 |